One Kansas City priest is especially thankful he's able to continue his calling this American Heart Month, thanks to a new ...

A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.

Cytokinetics, Incorporated CYTK announced that the European Commission (EC) has approved Myqorzo (aficamten), 5 mg, 10 mg, 15 ...

Dementia prevention is a critical area of research, as experts want to understand what people can do to decrease dementia risk. A recent study found that more than 5 years of taking medications like ...

We're just setting up a generation of people to move through life, having their cardiovascular events earlier and more severe ...

Nancy Guthrie’s health update has sparked medical concerns about abruptly stopping heart medications. Cardiologists warn that ...

Dr. Sadiya Khan, Director, Center for Population Science and Aging, Northwestern Medicine, joins John Williams to talk about the public splash around weight loss medications and how they interact ...

Cardiac amyloidosis is a progressive condition that affects the heart and other organs, but new FDA-approved drugs are prolonging the lives of those affected and early identification is now possible.

Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study. Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to ...

Scientists have created a three-dimensional "heart-on-a-chip" (HOC) that could provide a breakthrough in the fight against the world's leading cause of death, cardiovascular disease. One major ...

An analysis of cardiac arrest records in a U.S. registry revealed that people with drug overdose cardiac arrests were more likely to be younger, have fewer health conditions and have higher survival ...